08:11 AM EST, 11/10/2025 (MT Newswires) -- Wave Life Sciences ( WVE ) reported a Q3 net loss Monday of $0.32 per diluted share, narrower than a loss of $0.47 a year earlier.

Analysts polled by FactSet expected a loss of $0.30.

Revenue for the quarter ended Sept. 30 was $7.6 million, compared with a revenue loss of $7.7 million a year earlier.

Analysts surveyed by FactSet expected revenue of $12.6 million.

As of Sept. 30, the company said it had $196.2 million in cash and or cash equivalents on hand, and expected it could fund operations through Q2 of 2027.

The company's shares were down more than 1% in recent Monday premarket activity.